Respiratory Syncytial Virus

Common Name(s)

Respiratory Syncytial Virus

Respiratory syncytial virus (RSV) is a very common virus that causes infections in the lungs and respiratory tract. Most children have been infected with the virus by age 2, though it may also affect adults. Symptoms are generally mild and similar to that of a common cold. RSV can be severe in the case of premature babies, infants with underlying health conditions, older adults, adults with heart and lung disease, or anyone with a weak immune system.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Respiratory Syncytial Virus" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Respiratory Syncytial Virus" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Respiratory Syncytial Virus" returned 1558 free, full-text research articles on human participants. First 3 results:

Estimating influenza and respiratory syncytial virus-associated mortality in Western Kenya using health and demographic surveillance system data, 2007-2013.
 

Author(s): Gideon O Emukule, Peter Spreeuwenberg, Sandra S Chaves, Joshua A Mott, Stefano Tempia, Godfrey Bigogo, Bryan Nyawanda, Amek Nyaguara, Marc-Alain Widdowson, Koos van der Velden, John W Paget

Journal:

 

Influenza and respiratory syncytial virus (RSV) associated mortality has not been well-established in tropical Africa.

Last Updated: 7 Jul 2017

Go To URL
Defining the vaccination window for respiratory syncytial virus (RSV) using age-seroprevalence data for children in Kilifi, Kenya.
 

Author(s): Joyce U Nyiro, Ivy K Kombe, Charles J Sande, James Kipkoech, Patience K Kiyuka, Clayton O Onyango, Patrick K Munywoki, Timothy M Kinyanjui, D James Nokes

Journal:

 

Respiratory syncytial virus (RSV) is an important cause of lower respiratory tract disease in early life and a target for vaccine prevention. Data on the age-prevalence of RSV specific antibodies will inform on optimizing vaccine delivery.

Last Updated: 22 May 2017

Go To URL
Respiratory syncytial virus-neutralizing serum antibody titers in infants following palivizumab prophylaxis with an abbreviated dosing regimen.
 

Author(s): Jennifer Claydon, Amitava Sur, Allison Callejas, Mihoko Ladd, Eddie Kwan, Richard Taylor, Stuart E Turvey, Alfonso Solimano, Pascal M Lavoie, Nico Marr

Journal:

 

Monthly injections of palivizumab during the respiratory syncytial virus (RSV) season in at-risk infants reduces RSV-associated hospitalizations. However, the additive effect of naturally acquired immunity remains unclear. The objective of this study was to assess total neutralizing ...

Last Updated: 24 Apr 2017

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Respiratory Syncytial Virus" returned 109 free, full-text review articles on human participants. First 3 results:

Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine Design.
 

Author(s): Emma Rey-Jurado, Alexis M Kalergis

Journal:

 

The human respiratory syncytial virus (hRSV) is the causative agent for high rates of hospitalizations due to viral bronchiolitis and pneumonia worldwide. Such a disease is characterized by an infection of epithelial cells of the distal airways that leads to inflammation and subsequently ...

Last Updated: 9 Mar 2017

Go To URL
[Potential neurocognitive consequences of infection by human respiratory syncytial virus].
 

Author(s): Juan Carlos Flores, Karen Bohmwald, Janyra Espinoza, Crlstlna Jara, Marcela Peña, Rodrigo Hoyos-Bachiloglu, Carolina Iturriaga, Alexis M Kalergis, Arturo Borzutzky

Journal: Rev Chilena Infectol. 2016 Oct;33(5):537-542.

 

Human respiratory syncytial virus (RSV) infection remains as a major cause of morbidity and mortality among pediatric population. Immune response is poor and unable to establish a long term effective protection against this virus. Of particular interest has been the description of ...

Last Updated: 23 Jan 2017

Go To URL
Drug candidates and model systems in respiratory syncytial virus antiviral drug discovery.
 

Author(s): Elisabeth Heylen, Johan Neyts, Dirk Jochmans

Journal: Biochem. Pharmacol.. 2017 Mar;127():1-12.

 

The development of antiviral strategies to prevent or treat respiratory syncytial virus (RSV) infections is of great importance, especially considering the fact that RSV is one of the most important causes of pediatric respiratory infections. However, despite intense efforts, there ...

Last Updated: 27 Sep 2016

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Last Updated: 7 Aug 2017

Go to URL

Last Updated: 31 Jan 2017

Go to URL